Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4790822
Max Phase: Preclinical
Molecular Formula: C38H38ClFN6O6S
Molecular Weight: 761.28
Molecule Type: Unknown
Associated Items:
ID: ALA4790822
Max Phase: Preclinical
Molecular Formula: C38H38ClFN6O6S
Molecular Weight: 761.28
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(O[C@H](Cc4ccccc4OCc4ccnn4C)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl
Standard InChI: InChI=1S/C38H38ClFN6O6S/c1-23-26(8-9-28(34(23)39)49-19-18-46-16-14-44(2)15-17-46)32-33-36(41-22-42-37(33)53-35(32)29-10-11-31(40)51-29)52-30(38(47)48)20-24-6-4-5-7-27(24)50-21-25-12-13-43-45(25)3/h4-13,22,30H,14-21H2,1-3H3,(H,47,48)/t30-/m1/s1
Standard InChI Key: AQVKIYGPKKZICS-SSEXGKCCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 761.28 | Molecular Weight (Monoisotopic): 760.2246 | AlogP: 6.73 | #Rotatable Bonds: 14 |
Polar Surface Area: 128.21 | Molecular Species: ACID | HBA: 12 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.95 | CX Basic pKa: 7.65 | CX LogP: 3.83 | CX LogD: 3.69 |
Aromatic Rings: 6 | Heavy Atoms: 53 | QED Weighted: 0.13 | Np Likeness Score: -0.98 |
1. Szlavik Z,Csekei M,Paczal A,Szabo ZB,Sipos S,Radics G,Proszenyak A,Balint B,Murray J,Davidson J,Chen I,Dokurno P,Surgenor AE,Daniels ZM,Hubbard RE,Le Toumelin-Braizat G,Claperon A,Lysiak-Auvity G,Girard AM,Bruno A,Chanrion M,Colland F,Maragno AL,Demarles D,Geneste O,Kotschy A. (2020) Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor., 63 (22): [PMID:33146521] [10.1021/acs.jmedchem.0c01234] |
Source(1):